Artículos por temáticas

Coenzyme Q10 and the Blood-Brain Barrier: An Overview

Mantle D, Hargreaves I.

J Clin Med. 2025 Apr 16;14(8):2748. doi: 10.3390/jcm14082748.

A Focus on the Link Between Metal Dyshomeostasis, Norepinephrine, and Protein Aggregation

Bacchella C, Capucciati A, Monzani E.

Antioxidants (Basel). 2025 Mar 15;14(3):347. doi: 10.3390/antiox14030347.

Contributions of Europeans to Xenotransplantation Research: 2. Pig Islet and Cell Xenotransplantation

Bottino R, Vasudev K, Iwanczyk Z, Cozzi E, Cooper DKC.

Transpl Int. 2025 Apr 17;38:14143. doi: 10.3389/ti.2025.14143. eCollection 2025.

Sulforaphane: An emerging star in neuroprotection and neurological disease prevention

Wu N, Luo Z, Deng R, Zhang Z, Zhang J, Liu S, Luo Z, Qi Q.

Biochem Pharmacol. 2025 Mar;233:116797. doi: 10.1016/j.bcp.2025.116797. Epub 2025 Feb 8.

The mechanism of super-enhancer regulation of gene expression and research progress in neurodegenerative diseases

Zhao S, Yang Q, Gao C.

Rev Invest Clin. 2025 Apr 9;77(2):35-43. doi: 10.24875/RIC.24000246.

Psychometric properties of 3-meter backward walk test (3MBWT) in people with Parkinson disease

Barta K, Boddy AH, Flores M, Perry L, Sawyer K, Campbell A.

Physiother Theory Pract. 2025 Mar;41(3):656-663. doi: 10.1080/09593985.2024.2348034. Epub 2024 Apr 28.

Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases

Deng S, Xie H, Xie B.

Stem Cell Res Ther. 2025 Apr 6;16(1):167. doi: 10.1186/s13287-025-04285-7.

Ataxia-Parkinsonism in a Patient With Double-Positive Anti-Hu and Anti-NMDAR Antibodies

Cunha C, Faustino P, Carvalho I, Morgadinho A, Cunha R, Reis-Carneiro D.

Neurohospitalist. 2025 May 19:19418744251342295. doi: 10.1177/19418744251342295. Online ahead of print.

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity

de Rezende VL, de Aguiar da Costa M, Martins CD, Mathias K, Gonçalves CL, Barichello T, Petronilho F.

Neurochem Res. 2025 Mar 4;50(2):112. doi: 10.1007/s11064-025-04361-7.

Identification of markers for neurescence through transcriptomic profiling of postmortem human brains

Dehkordi SK, Sajedi S, Heshmat A, Orr ME, Zare H.

Res Sq [Preprint]. 2025 Apr 9:rs.3.rs-5903682. doi: 10.21203/rs.3.rs-5903682/v1.

A Meta-Analysis of Medication Reduction and Motor Outcomes After Awake Versus Asleep Deep Brain Stimulation for Parkinson Disease

Li L, Rae AI, Burchiel KJ.

Neurosurgery. 2025 Mar 1;96(3):481-493. doi: 10.1227/neu.0000000000003138. Epub 2024 Aug 28.

Advancements in PROTAC-based therapies for neurodegenerative diseases

Kong D, Meng L, Lin P, Wu G.

Future Med Chem. 2025 Mar;17(5):591-605. doi: 10.1080/17568919.2025.2463310. Epub 2025 Feb 11.

A comprehensive review on the bioactivity and pharmacological attributes of Withania somnifera

Khalid MU, Sultan MT, Baig I, Abbas A, Noman AM, Zinedine A, Bartkiene E, Rocha JM.

Nat Prod Res. 2025 May 8:1-15. doi: 10.1080/14786419.2025.2499070. Online ahead of print.

Glycosphingolipids in neurodegeneration - Molecular mechanisms, cellular roles, and therapeutic perspectives

Hülsmeier AJ.

Neurobiol Dis. 2025 Apr;207:106851. doi: 10.1016/j.nbd.2025.106851. Epub 2025 Feb 18.

Chemokines in neurodegenerative diseases

Vida H, Sahar M, Nikdouz A, Arezoo H.

Immunol Cell Biol. 2025 Mar;103(3):275-292. doi: 10.1111/imcb.12843. Epub 2024 Dec 26.